Search Results

FDA Approves New Targeted Treatment for Acute Myeloid Leukemia

Rye Brook, N.Y., July , – The U.S. Food and Drug Administration (FDA) last week approved quizartinib (Vanflyta®) in combination with standard chemoth…

The Follicular Lymphoma Foundation Joins Forces With The Leukemia & Lymphoma Society to Bring Hope to Those Living With Follicular Lymphoma

AUGUST , - The Follicular Lymphoma Foundation (FLF) and The Leukemia & Lymphoma Society (LLS) have joined forces in an unprecedented strategic partne…

The Leukemia & Lymphoma Society and Blood Cancer UK Team Up to Award $4.25M for Research into Ways to Prevent Leukemia

RYE BROOK, N.Y., February , — The Leukemia & Lymphoma Society (LLS) and Blood Cancer UK announced today a , $. million grant to launch a research pro…

The Leukemia & Lymphoma Society Honors 6 Scientists for their Contributions to Blood Cancer Research at Event During American Society of Hematology Annual Meeting

San Diego, December , – Using the latest genetic tools, Elvin Wagenblast, Ph.D., is dissecting blood cells to explain exactly why and how some go fr…

Shred For Red: Communities Nationwide to Join Olympians at Deer Valley Resort to Support Blood Cancer Patients

(RYE BROOK, N.Y., November , ) - The Leukemia & Lymphoma Society (LLS) is kicking off the ski season by gathering communities nationwide at LLS’s "Shr…

Skies Across North America to Light Up This Fall in Support of Blood Cancer Patients

The Leukemia & Lymphoma Society kicks off philanthropic campaign Light The Night; communities nationwide encouraged to learn why awareness and support…

The Leukemia & Lymphoma Society Honors Five Outstanding Blood Cancer Scientists with 2023 Awards

RYE BROOK, N.Y., December , – The Leukemia & Lymphoma Society (LLS) recognized and celebrated the outstanding contributions of five scientific invest…

The Leukemia & Lymphoma Society (LLS) Invests Nearly $6.5 Million in Research Investigating the Causes of Inequitable Access to Blood Cancer Treatment and Care

LLS’s Equity in Access Research Program Awards Four New Grants to Researchers Studying the Relationship Between Health Insurance and Access to Care an…

The Leukemia & Lymphoma Society Names Lore Gruenbaum, Ph.D., New Chief Scientific Officer

Lore Gruenbaum, Ph.D., will oversee the planning and execution of the strategy for all LLS’s research programs Dr. Gruenbaum succeeds Lee Greenberger,…

The Leukemia & Lymphoma Society Rings Nasdaq Bell to Mark 75 Years of Progress and Announce its Bold Goal for the Future

The organization will enable blood cancer patients to gain one million years of life by

The Leukemia & Lymphoma Society’s Light The Night Events Lead the Charge Against Blood Cancer

The Leukemia & Lymphoma Society’s Light The Night Events Lead the Charge Against Blood Cancer.

Leukemia Survivor Named National ‘Visionary of the Year’ Redefining What’s Possible After Diagnosis

The Leukemia & Lymphoma Society (LLS) Announces National Winners of Evolutionary ‘Visionaries of the Year’ Campaign; Funds Raised Will Help LLS Improv…

LLS Experts: CAR T-therapy Benefits Outweigh Risks for Appropriate Patients

Rye Brook, N.Y., February , — The Leukemia & Lymphoma Society (LLS) has been closely monitoring reports from the U.S. Food and Drug Administration (F…

National Film Festival Debuts Documentary About First-of-Its-Kind Blood Cancer Master Clinical Trial

“Coloring Outside the Lines” follows the journeys of four patients with aggressive leukemia and the groundbreaking clinical trial designed to save th…

The LLS Children’s Initiative Latest News

The LLS Children’s Initiative is a $ million effort to take on children’s cancer through every facet of our mission: Research, Patient Education and …

Myelodysplastic syndromes (MDS) diagnosis

An accurate myelodysplastic syndromes (MDS) diagnosis is important to help your doctor establish your MDS subtype, estimate how the disease will progr…

25 Patient and Provider Groups Applaud Supreme Court Ruling, Though Express Concern About Other Plaintiffs Keeping FDA Authority Challenge Alive

WASHINGTON, D.C., June , – Our organizations, representing patients with serious health conditions and disabilities and their providers, applaud the…

Legal advocacy

Public policy and advocacy

Working closely with dedicated volunteers, we advocate for safe and effective treatments, accessible healthcare for all patients, and—most importantly…

DIY: Your movement to cure blood cancer

Every dollar makes a difference. With Blood Cancer United DIY, you can turn any activity or event into a way to support the organiz…

Legislative Action Center

Webcasts y Videos en Español

Estos programas están disponibles en español. Haga clic en los enlaces a continuación para acceder a transmisiones web, repeticiones de audio, transcr…

Blood Cancer United PedAL

Clinical Trial Support Center (CTSC)

Our Clinical Trial Nurse Navigators have expertise in pediatric and adult blood cancers and provide free assistance about the clinical trial process.

Infections, low blood counts, and iron overload in children and teens

Blood cancer treatment can make patients susceptible to low blood counts and infections, which may be serious and difficult to treat.